| HOME >> MEDICINE >> TECHNOLOGY |
Brand erosion post patent expiry 15
Biosimilars market 15
Russia - Drug Industry Infrastructure analysis 17
Pharmaceutical industry infrastructure overview 17
Related reports 19
Upcoming related reports 19
TABLE OF CONTENTS 20
2. Russia - Socio-demographic and economic analysis 21
Russia - Key findings 21
Socio-demographic trends 21
Socio-economic trends 21
Russia - Demographic trends 23
Population in Russia expected to decline rapidly 24
Population growth rate in Russia remains low due to low birth rates 24
Proportion of elderly people will remain lower than in all other markets 27
Life expectancy in Russia is poor and will remain so 27
Russia - Disease burden in Russia 29
Cardiovascular diseases and injuries are the leading cause of death and account for the highest disease burden in Russia 31
High level of preventable deaths in Russia 31
HIV/AIDS presents a worrying trend in Russia 32
Russia - Political climate 33
The political climate in Russia has undergone recent changes 33
Russia remains a centralized country with power centered on Moscow 33
Russia - Economic climate 34
Economy - recovery post-recession is slow but will gain momentum from 2010 34
Economic growth is impacted by income inequality in Russia 35
Russia - Business environment 37
Although impediments to investing in Russia remain, the government is prioritizing healthcare 37
The recession has impacted unemployment levels 37
Russia has a uniform tax rate 38
Pharmaceuticals are subject to a reduced VAT rate of 10% 38
Corruption significantly impedes foreign investment in Russia 39
Local knowledge is critical for business success 39
3. Russia - Healthcare system and drug regulatory analysis 40
Russia - Key findings 40
Healthcare expenditure 40
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |